Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments

April 2, 2026

Hemophagocytic Lymphohistiocytosis Market Outlook Report 2026-2030 – Increasing Autoimmune Disease Prevalence Fuels HLH Market Expansion at 5.8% CAGR

April 2, 2026

BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

April 2, 2026

All aboard! Saskatoon’s ‘iconic’ Prairie Lily will return this spring

April 2, 2026

Rally House Expands CoMo Footprint with Third Store

April 2, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » XerpaAI Secures $6 Million Seed Funding to Power the Future of AI-Driven Growth
Press Release

XerpaAI Secures $6 Million Seed Funding to Power the Future of AI-Driven Growth

By News RoomJuly 9, 20255 Mins Read
XerpaAI Secures  Million Seed Funding to Power the Future of AI-Driven Growth
Share
Facebook Twitter LinkedIn Pinterest Email

SILICON VALLEY, Calif., July 09, 2025 (GLOBE NEWSWIRE) — XerpaAI, a next-generation AI growth platform designed to accelerate the expansion of disruptive businesses, today announced the successful close of its $6 million seed funding round, led by UFLY Capital. The investment will support product innovation, international expansion, and strategic hiring as the company scales operations across Silicon Valley, Tokyo, and Singapore.

Inspired by the role of Sherpa guides who assist climbers to summit Mount Everest, XerpaAI positions itself as a strategic “growth Sherpa” for companies navigating the competitive landscapes of blockchain, AI, and other emerging technologies. By harnessing the power of AI and social ecosystems, the platform helps clients drive user acquisition, amplify brand reach, and optimize distribution—at scale.

“We founded XerpaAI to solve a critical problem we faced as entrepreneurs: growth was costly, inefficient, and unsustainable,” said Sean Son, Co-founder and CEO of XerpaAI. “With AI and social graph-based strategies, we’ve reimagined the entire growth lifecycle into a scalable, intelligent engine.”

A New Era: AI Growth Agent (AGA)

XerpaAI introduces the concept of the AI Growth Agent (AGA)—a productized, data-driven system that replaces traditional marketing silos with end-to-end growth intelligence. The platform enables businesses to:

  • Instantly generate compelling content using large-scale AI models.
  • Distribute that content through a curated network of tens of thousands of KOLs, KOCs, and community leaders.
  • Collect real-time market feedback and data to refine campaigns and inform product decisions.

Unlike traditional marketing, which often focuses on brand visibility, XerpaAI’s AGAs are outcome-focused—measuring success through user acquisition, retention, and direct business results.

Market Opportunity and Competitive Edge

With global tech companies spending an estimated $600 billion to $1 trillion annually on growth—largely on content creation and distribution—XerpaAI addresses a massive, underserved market. The company draws inspiration from AppLovin, which helped catalyze mobile app adoption in the 2010s. XerpaAI aims to serve a similar role for the AI era.

“AppLovin was the Sherpa for the mobile internet wave. XerpaAI will be the Sherpa for the AI-native generation,” Son added.

A Strategic Investment and Ecosystem Alignment

UFLY Capital, a leading investment and incubation firm, led the funding round. The partnership reflects deep alignment: Son is also a key LP in the fund, reinforcing mutual confidence in XerpaAI’s long-term vision. The capital will be used to deepen product capabilities and expand global operations.

Currently, 80% of XerpaAI’s clients come from the blockchain space, with the remainder in the AI sector. The company’s solution is especially effective for categories requiring market education, where peer-to-peer trust and social amplification are more impactful than conventional advertising.

XerpaAI maintains a close operational relationship with UXLINK, a leading decentralized social infrastructure platform. Though independent, the companies collaborate deeply across ecosystems, providing mutual value to shared clients and contributing to Web3 growth initiatives.

Building for Scale

The company currently operates with a lean, high-impact team spread across Tokyo, Singapore, and Silicon Valley, leveraging its own AI technology to maximize efficiency. Future hiring will focus on sales, compliance, and finance as the platform scales.

Looking ahead, XerpaAI expects to reach profitability in the near term, with plans for a potential private financing round in 2026. A public listing may also be considered as part of the company’s long-term roadmap.

About XerpaAI

XerpaAI is an AI-powered growth platform designed to help innovative businesses scale efficiently. By combining AI-generated content, data-driven distribution, and deep social network integration, XerpaAI transforms how companies acquire users, influence markets, and drive results.

For media inquiries, partnerships, or more information, visit www.xerpaai.com

Media Contact Information: 
Email : [email protected]
Twitter : https://x.com/xerpaai/

PR Contact: 
Rachita Chettri
MediaX Agency
[email protected]

Disclaimer: This content is provided by XerpaAI. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility . Globenewswire does not endorse any content on this page.

Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/49c6a1f4-0f31-401e-b29a-c238b42d6128

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments

Hemophagocytic Lymphohistiocytosis Market Outlook Report 2026-2030 – Increasing Autoimmune Disease Prevalence Fuels HLH Market Expansion at 5.8% CAGR

BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

Rally House Expands CoMo Footprint with Third Store

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

HUBG SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

Centenary Anniversary: Presenting the “Legion 100” tulip

SMCI SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Super Micro (SMCI) Investors of Securities Class Action Deadline on May 26, 2026

Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month

Editors Picks

Hemophagocytic Lymphohistiocytosis Market Outlook Report 2026-2030 – Increasing Autoimmune Disease Prevalence Fuels HLH Market Expansion at 5.8% CAGR

April 2, 2026

BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

April 2, 2026

All aboard! Saskatoon’s ‘iconic’ Prairie Lily will return this spring

April 2, 2026

Rally House Expands CoMo Footprint with Third Store

April 2, 2026

Latest News

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

April 2, 2026

HUBG SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

April 2, 2026

Centenary Anniversary: Presenting the “Legion 100” tulip

April 2, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version